Potential Treatments for COVID-19; a Narrative Literature Review.
Identifieur interne : 000323 ( PubMed/Checkpoint ); précédent : 000322; suivant : 000324Potential Treatments for COVID-19; a Narrative Literature Review.
Auteurs : Ali Rismanbaf [Iran]Source :
- Archives of academic emergency medicine [ 2645-4904 ] ; 2020.
Abstract
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19, which has been recognized as a pandemic by the World Health Organization (WHO) on March 11th. There is still no vaccine or definitive treatment for this virus because its pathogenesis and proliferation pathways are still unknown. Therefore, in this article, new potential COVID-19 therapies are briefly reviewed.
PubMed: 32232214
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32232214Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Potential Treatments for COVID-19; a Narrative Literature Review.</title><author><name sortKey="Rismanbaf, Ali" sort="Rismanbaf, Ali" uniqKey="Rismanbaf A" first="Ali" last="Rismanbaf">Ali Rismanbaf</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan</wicri:regionArea><wicri:noRegion>Isfahan</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32232214</idno><idno type="pmid">32232214</idno><idno type="wicri:Area/PubMed/Corpus">000438</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000438</idno><idno type="wicri:Area/PubMed/Curation">000438</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000438</idno><idno type="wicri:Area/PubMed/Checkpoint">000323</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000323</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Potential Treatments for COVID-19; a Narrative Literature Review.</title><author><name sortKey="Rismanbaf, Ali" sort="Rismanbaf, Ali" uniqKey="Rismanbaf A" first="Ali" last="Rismanbaf">Ali Rismanbaf</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan</wicri:regionArea><wicri:noRegion>Isfahan</wicri:noRegion></affiliation></author></analytic><series><title level="j">Archives of academic emergency medicine</title><idno type="eISSN">2645-4904</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19, which has been recognized as a pandemic by the World Health Organization (WHO) on March 11<sup>th</sup>. There is still no vaccine or definitive treatment for this virus because its pathogenesis and proliferation pathways are still unknown. Therefore, in this article, new potential COVID-19 therapies are briefly reviewed.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32232214</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2645-4904</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Archives of academic emergency medicine</Title><ISOAbbreviation>Arch Acad Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Potential Treatments for COVID-19; a Narrative Literature Review.</ArticleTitle><Pagination><MedlinePgn>e29</MedlinePgn></Pagination><Abstract><AbstractText>SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19, which has been recognized as a pandemic by the World Health Organization (WHO) on March 11<sup>th</sup>. There is still no vaccine or definitive treatment for this virus because its pathogenesis and proliferation pathways are still unknown. Therefore, in this article, new potential COVID-19 therapies are briefly reviewed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rismanbaf</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Arch Acad Emerg Med</MedlineTA><NlmUniqueID>101740147</NlmUniqueID><ISSNLinking>2645-4904</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case reports</Keyword><Keyword MajorTopicYN="N">Clinical trial</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Drug therapy</Keyword><Keyword MajorTopicYN="N">Review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32232214</ArticleId><ArticleId IdType="pmc">PMC7085862</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Genet Genomics. 2020 Feb 13;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32173287</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virol Sin. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32034637</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation><ArticleIdList><ArticleId IdType="pubmed">32032529</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>F1000Res. 2020 Feb 21;9:129</Citation><ArticleIdList><ArticleId IdType="pubmed">32194944</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Korean Med Sci. 2020 Feb 17;35(6):e79</Citation><ArticleIdList><ArticleId IdType="pubmed">32056407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mol Inform. 2020 Mar 11;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32162456</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 16;43(0):E014</Citation><ArticleIdList><ArticleId IdType="pubmed">32061198</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Rismanbaf, Ali" sort="Rismanbaf, Ali" uniqKey="Rismanbaf A" first="Ali" last="Rismanbaf">Ali Rismanbaf</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000323 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000323 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32232214
|texte= Potential Treatments for COVID-19; a Narrative Literature Review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32232214" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |